Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 6—June 2015
Research

Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 20131

Rania A. TohmeComments to Author , Jeannot François, Kathleen Wannemuehler, Preetha Iyengar, Amber Dismer, Paul Adrien, Terri B. Hyde, Barbara J. Marston, Kashmira A. Date, Eric D. Mintz, and Mark A. Katz
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.A. Tohme, K. Wannemuehler, P. Iyengar, A. Dismer, T.B. Hyde, B.J. Marston, K. Date, E. Mintz); Ministry of Public Health and Population, Port-au-Prince, Haiti (J. Francois, P. Adrien); Centers for Disease Control and Prevention, Port-au-Prince (M.A. Katz)

Main Article

Table 4

Principal reasons for not receiving oral cholera vaccine, by area, Haiti, 2013*

Reason Petite Anse, no. ( %) Cerca Carvajal, no. ( %)
First dose
No. who did not receive dose 348 117
Absent during the campaign 141 (40.5) 63 (53.8)
Did not hear about the vaccination activities 41 (11.8) 15 (12.8)
Busy/no time 34 (9.8) 7 (6.0)
Sick during the campaign 14 (4.0) 4 (3.4)
Didn’t think vaccination was important/necessary 20 (5.7) 2 (1.7)
Don’t think vaccines are safe/vaccines can harm 10 (2.9) 2 (1.7)
Vaccines not available 5 (1.4) 4 (3.4)
Didn’t know when or where to go 6 (1.7) 2 (1.7)
Clinic closed/vaccinator not there/vaccinator refused to vaccinate 6 (1.7) 2 (1.7)
Other
71 (20.4)
16 (13.7)
Second dose†
No. who did not receive dose 73 54
Absent during second campaign 21 (28.8) 13 (24.1)
Clinic closed/vaccinator refused to vaccinate 5 (6.8) 1 (1.9)
Busy/no time 4 (5.5) 11 (20.4)
Bad experience/ adverse event after first dose 6 (8.2) 2 (3.7)
Did not know needed a second dose 3 (4.1) 1 (1.9)
Sick during the campaign 2 (2.7) Not reported
Didn’t know when or where to go Not reported 2 (3.7)
Forgot to go 2 (2.7) 1 (1.9)
Vaccines not available 1 (1.4) 7 (13.0)
Other 29 (39.7) 9 (16.7)

*Categories are mutually exclusive because respondents were allowed to give only 1 primary reason. Percentages are unweighted for the purpose of description only.
†Of those who received the first dose.

Main Article

1Results from this study were partially presented at the 49th US–Japan Conference on Cholera and Other Enteric Bacterial Infections; 2015 Jan 14–16; Gainesville, Florida, USA.

Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external